Population Pharmacodynamics of IPX066: An Oral Extended-Release Capsule Formulation of Carbidopa–Levodopa, and Immediate-Release Carbidopa–Levodopa in Patients With Advanced Parkin...

por Mao, Zhongping, Hsu, Ann, Gupta, Suneel, Modi, Nishit B
Publicado 2013

Clinical Pharmacokinetics of IPX066: Evaluation of Dose Proportionality and Effect of Food in Healthy Volunteers

por Yao, Hsuan-Ming, Hsu, Ann, Gupta, Suneel, Modi, Nishit B.
Publicado 2016

Comparison of the pharmacokinetics of an oral extended‐release capsule formulation of carbidopa‐levodopa (IPX066) with immediate‐release carbidopa‐levodopa (Sinemet(®)), sustained‐...

por Hsu, Ann, Yao, Hsuan‐Ming, Gupta, Suneel, Modi, Nishit B.
Publicado 2015

Variation of picture angles and its effect on the Concealed Information Test

por Hsu, Ann, Lo, Yu-Hui, Ke, Shi-Chiang, Lin, Lin, Tseng, Philip
Publicado 2020

Erythroid‐specific inactivation of Slc12a6/Kcc3 by EpoR promoter‐driven Cre expression reduces K‐Cl cotransport activity in mouse erythrocytes

por Shmukler, Boris E., Rivera, Alicia, Nishimura, Katherine, Hsu, Ann, Wohlgemuth, Jay G., Dlott, Jeffrey S., Michael Snyder, L., Brugnara, Carlo, Alper, Seth L.
Publicado 2022

Long-Term Treatment with Extended-Release Carbidopa–Levodopa (IPX066) in Early and Advanced Parkinson’s Disease: A 9-Month Open-Label Extension Trial

por Waters, Cheryl H., Nausieda, Paul, Dzyak, Lyudmila, Spiegel, Joerg, Rudzinska, Monika, Silver, Dee E., Tsurkalenko, Elena S., Kell, Sherron, Hsu, Ann, Khanna, Sarita, Gupta, Suneel
Publicado 2015

Conversion to IPX066 from Standard Levodopa Formulations in Advanced Parkinson’s Disease: Experience in Clinical Trials

por Nausieda, Paul A., Hsu, Ann, Elmer, Lawrence, Gil, Ramon A., Spiegel, Joerg, Singer, Carlos, Khanna, Sarita, Rubens, Robert, Kell, Sherron, Modi, Nishit B., Gupta, Suneel
Publicado 2015